USA Gastric Motility Disorder Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gastric Motility Disorder Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gastric Motility Disorder Drug market. Detailed analysis of key players, along with key growth strategies adopted by Gastric Motility Disorder Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Concert Pharmaceuticals, Inc

    • ChironWells GmbH

    • Targacept, Inc

    • Helsinn Healthcare SA

    • Theravance, Inc

    By Type:

    • Velusetrag

    • Ipamorelin

    • TD-8954

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Home Use

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastric Motility Disorder Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2016 to 2027

      • 1.3.2 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2016 to 2027

      • 1.3.3 USA Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2016 to 2027

      • 1.3.4 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2016 to 2027

      • 1.4.2 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2016 to 2027

      • 1.4.3 USA Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Gastric Motility Disorder Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastric Motility Disorder Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Velusetrag

      • 3.4.2 Market Size and Growth Rate of Ipamorelin

      • 3.4.3 Market Size and Growth Rate of TD-8954

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Gastric Motility Disorder Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastric Motility Disorder Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gastric Motility Disorder Drug in Hospital

      • 4.4.2 Market Size and Growth Rate of Gastric Motility Disorder Drug in Clinic

      • 4.4.3 Market Size and Growth Rate of Gastric Motility Disorder Drug in Home Use

    5 Market Analysis by Regions

    • 5.1 USA Gastric Motility Disorder Drug Production Analysis by Regions

    • 5.2 USA Gastric Motility Disorder Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Gastric Motility Disorder Drug Landscape Analysis

    • 6.1 West USA Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 6.2 West USA Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    7 South USA Gastric Motility Disorder Drug Landscape Analysis

    • 7.1 South USA Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 7.2 South USA Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    8 Middle West USA Gastric Motility Disorder Drug Landscape Analysis

    • 8.1 Middle West USA Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 8.2 Middle West USA Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    9 Northeast USA Gastric Motility Disorder Drug Landscape Analysis

    • 9.1 Northeast USA Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 9.2 Northeast USA Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Concert Pharmaceuticals, Inc

        • 10.1.1 Concert Pharmaceuticals, Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 ChironWells GmbH

        • 10.2.1 ChironWells GmbH Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Targacept, Inc

        • 10.3.1 Targacept, Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Helsinn Healthcare SA

        • 10.4.1 Helsinn Healthcare SA Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Theravance, Inc

        • 10.5.1 Theravance, Inc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2016 to 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2016 to 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2016 to 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure USA Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Gastric Motility Disorder Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Gastric Motility Disorder Drug

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastric Motility Disorder Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Gastric Motility Disorder Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Velusetrag

    • Figure Market Size and Growth Rate of Ipamorelin

    • Figure Market Size and Growth Rate of TD-8954

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Gastric Motility Disorder Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Gastric Motility Disorder Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Home Use

    • Table USA Gastric Motility Disorder Drug Production by Regions

    • Table USA Gastric Motility Disorder Drug Production Share by Regions

    • Figure USA Gastric Motility Disorder Drug Production Share by Regions in 2016

    • Figure USA Gastric Motility Disorder Drug Production Share by Regions in 2021

    • Figure USA Gastric Motility Disorder Drug Production Share by Regions in 2027

    • Table USA Gastric Motility Disorder Drug Consumption by Regions

    • Table USA Gastric Motility Disorder Drug Consumption Share by Regions

    • Figure USA Gastric Motility Disorder Drug Consumption Share by Regions in 2016

    • Figure USA Gastric Motility Disorder Drug Consumption Share by Regions in 2021

    • Figure USA Gastric Motility Disorder Drug Consumption Share by Regions in 2027

    • Table West USA Gastric Motility Disorder Drug Consumption by Types from 2016 to 2027

    • Table West USA Gastric Motility Disorder Drug Consumption Share by Types from 2016 to 2027

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by Types in 2016

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by Types in 2021

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by Types in 2027

    • Table West USA Gastric Motility Disorder Drug Consumption by End-Users from 2016 to 2027

    • Table West USA Gastric Motility Disorder Drug Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2016

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2021

    • Figure West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2027

    • Table South USA Gastric Motility Disorder Drug Consumption by Types from 2016 to 2027

    • Table South USA Gastric Motility Disorder Drug Consumption Share by Types from 2016 to 2027

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by Types in 2016

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by Types in 2021

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by Types in 2027

    • Table South USA Gastric Motility Disorder Drug Consumption by End-Users from 2016 to 2027

    • Table South USA Gastric Motility Disorder Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2016

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2021

    • Figure South USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2027

    • Table Middle West USA Gastric Motility Disorder Drug Consumption by Types from 2016 to 2027

    • Table Middle West USA Gastric Motility Disorder Drug Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by Types in 2016

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by Types in 2021

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by Types in 2027

    • Table Middle West USA Gastric Motility Disorder Drug Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Gastric Motility Disorder Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2016

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2021

    • Figure Middle West USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2027

    • Table Northeast USA Gastric Motility Disorder Drug Consumption by Types from 2016 to 2027

    • Table Northeast USA Gastric Motility Disorder Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by Types in 2016

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by Types in 2021

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by Types in 2027

    • Table Northeast USA Gastric Motility Disorder Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Gastric Motility Disorder Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2016

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2021

    • Figure Northeast USA Gastric Motility Disorder Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Concert Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Concert Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Concert Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Concert Pharmaceuticals, Inc

    • Table Product and Service Introduction of Concert Pharmaceuticals, Inc

    • Table Company Profile and Development Status of ChironWells GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ChironWells GmbH

    • Figure Sales and Growth Rate Analysis of ChironWells GmbH

    • Figure Revenue and Market Share Analysis of ChironWells GmbH

    • Table Product and Service Introduction of ChironWells GmbH

    • Table Company Profile and Development Status of Targacept, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Targacept, Inc

    • Figure Sales and Growth Rate Analysis of Targacept, Inc

    • Figure Revenue and Market Share Analysis of Targacept, Inc

    • Table Product and Service Introduction of Targacept, Inc

    • Table Company Profile and Development Status of Helsinn Healthcare SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Healthcare SA

    • Figure Sales and Growth Rate Analysis of Helsinn Healthcare SA

    • Figure Revenue and Market Share Analysis of Helsinn Healthcare SA

    • Table Product and Service Introduction of Helsinn Healthcare SA

    • Table Company Profile and Development Status of Theravance, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance, Inc

    • Figure Sales and Growth Rate Analysis of Theravance, Inc

    • Figure Revenue and Market Share Analysis of Theravance, Inc

    • Table Product and Service Introduction of Theravance, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.